Ignite Creation Date:
2025-12-24 @ 5:02 PM
Ignite Modification Date:
2026-01-26 @ 5:54 AM
Study NCT ID:
NCT00057850
Status:
COMPLETED
Last Update Posted:
2013-02-11
First Post:
2003-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent squamous cell carcinoma of the hypopharynx | View |
| None | recurrent squamous cell carcinoma of the larynx | View |
| None | recurrent squamous cell carcinoma of the lip and oral cavity | View |
| None | recurrent squamous cell carcinoma of the oropharynx | View |
| None | recurrent squamous cell carcinoma of the paranasal sinus and nasal … | View |
| None | stage IV squamous cell carcinoma of the hypopharynx | View |
| None | stage IV squamous cell carcinoma of the larynx | View |
| None | stage IV squamous cell carcinoma of the lip and oral … | View |
| None | stage IV squamous cell carcinoma of the oropharynx | View |
| None | stage IV squamous cell carcinoma of the paranasal sinus and … | View |
| None | recurrent salivary gland cancer | View |
| None | salivary gland squamous cell carcinoma | View |
| None | stage IV salivary gland cancer | View |